Table 4.
Incident AF through 2001, ARIC | Incident AF through 2006, CHS | Meta-Analysis | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
No | Yes |
P Value |
No | Yes |
P Value |
HR (95% CI) |
P Value |
P Value for hetero- geneity |
||
By sex | ||||||||||
Female | ||||||||||
Number of SCD events | 83 | 9 | 93 | 26 | ||||||
Person-years | 103852 | 4561 | 36831 | 2973 | ||||||
Incidence rate(95% CI)c | 0.80 (0.64–0.99) | 1.97 (0.97–3.60) | 2.53 (2.06–3.09) | 8.74 (5.95–12.84) | ||||||
Hazard ratio (95% CI) | Model 1a | 1 [Referent] | 6.63 (3.13–14.00) | <.001 | 1 [Referent] | 2.86 (1.82–4.48) | <.001 | 3.58 (2.43–5.26) | <.001 | .06 |
Model 2b | 1 [Referent] | 4.12 (1.91–8.90) | <.001 | 1 [Referent] | 2.49 (1.57–3.95) | <.001 | 2.85 (1.92–4.23) | <.001 | .27 | |
Male | ||||||||||
Number of SCD events | 155 | 22 | 132 | 41 | ||||||
Person-years | 79235 | 6158 | 22046 | 2609 | ||||||
Incidence rate(95% CI)c | 1.96 (1.67–2.28) | 3.57 (2.30–5.31) | 5.99 (5.05–7.10) | 15.71 (11.57–21.34) | ||||||
Hazard ratio (95% CI) | Model 1a | 1 [Referent] | 5.01 (3.13–8.00) | <.001 | 1 [Referent] | 2.35 (1.62–3.40) | <.001 | 3.14 (2.35–4.21) | <.001 | .02 |
Model 2b | 1 [Referent] | 3.12 (1.93–5.04) | <.001 | 1 [Referent] | 1.99 (1.37–2.91) | <.001 | 2.36 (1.76–3.18) | <.001 | .15 | |
By race | ||||||||||
Non-Black | ||||||||||
Number of SCD events | 136 | 20 | 175 | 61 | ||||||
Person-years | 135086 | 8879 | 50528 | 5031 | ||||||
Incidence rate(95% CI)c | 1.01 (0.85–1.19) | 2.25 (1.42–3.41) | 3.46 (2.99–4.02) | 12.12 (9.43–15.58) | ||||||
Hazard ratio (95% CI) | Model 1a | 1 [Referent] | 4.38 (2.66–7.23) | <.001 | 1 [Referent] | 2.61 (1.92–3.54) | <.001 | 3.01 (2.32–3.90) | <.001 | .08 |
Model 2b | 1 [Referent] | 2.49 (1.49–4.17) | <.001 | 1 [Referent] | 2.16 (1.59–2.96) | <.001 | 2.24 (1.72–2.93) | <.001 | .64 | |
Black | ||||||||||
Number of SCD events | 102 | 11 | 50 | 6 | ||||||
Person-years | 48000 | 1840 | 8349 | 551 | ||||||
Incidence rate(95% CI)c | 2.13 (1.74–2.57) | 5.98 (3.17–10.35) | 5.99 (4.53–7.90) | 10.89 (4.89–24.24) | ||||||
Hazard ratio (95% CI) | Model 1a | 1 [Referent] | 8.39 (4.42–15.91) | <.001 | 1 [Referent] | 1.83 (0.77–4.34) | .17 | 4.89 (2.92–8.18) | <.001 | .006 |
Model 2b | 1 [Referent] | 5.77 (2.96–11.24) | <.001 | 1 [Referent] | 2.01 (0.81–4.97) | .14 | 3.98 (2.33–6.82) | <.001 | .07 |
Abbreviations: AF, atrial fibrillation; CI, confidence interval; SCD, sudden cardiac death
Cox proportional hazards model adjusted for age, sex, race, and field center
Model 1 additionally adjusted for baseline covariates: heart rate, smoking status, body mass index, hypertension, diabetes, coronary heart disease, heart failure, ECG-based left ventricular hypertrophy, use of beta-blockers, use of digoxin, and use of anti-arrhythmic drugs. In CHS, Model 2 was not adjusted for use of digoxin
Per 1000 person-years of follow-up